abciximab
推荐文章
n.
阿昔单抗[抗血栓药]；
双语例句
There is no apparent difference in early outcomes of patients treated with eptifibatide compared with patients treated with abciximab.
接受替非罗班治疗的患者的早期结果和接受阿昔单抗治疗的患者相比，不存在显著性差异。
权威例句
Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized tr...Abciximab improves both epicardial flow and myocardial reperfusion in ST-elevation myocardial infarction. Observations from the TIMI...
Combination Therapy With Abciximab Reduces Angiographically Evident Thrombus in Acute Myocardial Infarction A TIMI 14 Substudy
Abciximab facilitates the rate and extent of thrombolysis: results of the thrombolysis in myocardial infarction (TIMI) 14 trial. The...
Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction.
Abciximab in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention After Clopidogrel Pretreatment: Th...
Tirofiban and sirolimus-eluting stent vs abciximab and bare-metal stent for acute myocardial infarction: a randomized trial.
Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE ...
Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels. c7E3 Fab Antiplatelet Thera...
Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with per...
1. All patients were pretreated with 600 mg of clopidogrel and then randomly assigned to receive intravenous abciximab or a placebo during the procedure.
所有的病人都预先给与600mg的氯吡格雷，然后随机指派接受静脉阿西单抗或者过程中应用安慰剂。
youdao
2. Objectives: This prospective randomized trial evaluates the impact of early abciximab administration on angiographic and left ventricular function parameters.
目的：本前瞻性、随机试验旨在评价早期使用阿昔单抗对血管造影及左室功能参数的影响。
youdao
3. However, a large proportion of patients in the community are treated with eptifibatide, an agent that shares some but not all pharmacological properties with abciximab.
然而，却有相当比例的患者的治疗使用了替非罗班——具有阿昔单抗的部分药理学特性。
youdao
4. Background: Pooled data from randomized controlled trials suggest that the use of abciximab may be associated with a survival advantage in patients undergoing primary PCI for acute STEMI.
背景——来自随机对照试验的汇萃数据表明，因急性ST段抬高型心肌梗塞行直接PC I术后的患者，使用阿昔单抗可以提高生存率。
youdao
5. Background: Pooled data from randomized controlled trials suggest that the use of abciximab may be associated with a survival advantage in patients undergoing primary PCI for acute STEMI.
背景——来自随机对照试验的汇萃数据表明，因急性ST段抬高型心肌梗塞行直接PC I术后的患者，使用阿昔单抗可以提高生存率。
youdao
abciximab
